DUAL-ANTIBAX, an innovative antibacterial agent designed to meet the global demand for effective antimicrobial solutions amid the COVID-19 pandemic and growing hygiene concerns. With synergistic effects against pathogenic bacteria, DUAL-ANTIBAX offers a safer and more efficient alternative to traditional chemical-based or antibiotic antibacterial products.
In the market of antimicrobial and antibacterial agents is very huge globally which is contributed by the issue of COVID19, and growing safety and hygiene concerns. Skin problems and wound will become more severe once infected by the bacteria, and the treatment cost is enormous, with bacterial resistance to antibiotic issue.
UTM developed an Antibacterial Agent that has demonstrated synergistic effects against a variety of pathogenic bacteria.
Developed with synergistic effects against pathogenic bacteria, this agent offers a safer and more efficient alternative to traditional chemical-based or antibiotic antibacterial products. Unlike its competitors, it poses fewer risks of skin irritation, side effects, and bacterial resistance, making it a promising solution for pharmacies and related industries grappling with bacterial proliferation and treatment costs associated with infections.
Additionally, this discovery resolved issues in a number of related industries,most notably in the fight against bacterial proliferation.